Literature DB >> 12653785

Induction of the acrosome reaction in bull spermatozoa with plasmin.

I A Taitzoglou1, D A Chapman, G J Killian.   

Abstract

Proteolytic enzymes appear to have an essential role in multiple phases of mammalian fertilization. Plasmin, the active enzyme of the plasminogen activation system that stimulates fibrinolysis and proteolysis has a less well-documented role in reproduction. The current study was conducted to investigate the effect of the active protease, plasmin, on the ability of bovine sperm to undergo the acrosome reaction. Aliquots of freshly ejaculated bull sperm were incubated in capacitating conditions with 10 microg ml-1 of heparin for 4 h. Every 2 h an aliquot of spermatozoa was exposed to lysophosphatidylcholine (100 microg ml-1) or 0, 0.1, 1, 10 and 100 mU of plasmin to induce the acrosome reaction in capacitated spermatozoa. Plasmin increased the percentage of live acrosome reacted sperm after 4 h of incubation in the capacitation medium. Viability was not affected by any of the treatments. This study provides new information on bovine acrosome reaction during in vitro incubation with plasmin and indicates that this protease may participate in the proteolytic events that accompany fertilization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653785     DOI: 10.1046/j.1439-0272.2003.00541.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  2 in total

1.  Total urokinase-type plasminogen activator (uPA) levels in seminal plasma are associated with positive assisted reproductive technology outcomes.

Authors:  Juan Carlos Martinez-Soto; José Landeras; Marta Mollá; Irene Mondejar; María Nicolás; Laura Fernández-Olmedilla; Martina Trabalón; Pilar Coy; Joaquín Gadea
Journal:  J Assist Reprod Genet       Date:  2018-03-23       Impact factor: 3.412

2.  Urokinase-type plasminogen activator: a new target for male contraception?

Authors:  Ying Qin; Yan Han; Cheng-Liang Xiong; Hong-Gang Li; Lian Hu; Ling Zhang
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.